Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Royalindo Investa Wijaya Tbk. (INDO) vs Merck Tbk. (MERK) Price & Performance

Royalindo Investa Wijaya Tbk.Trade
Merck Tbk.Trade

Price performance (Past 24H)

Key statistics

Royalindo Investa Wijaya Tbk. vs Merck Tbk. — how do they compare? Royalindo Investa Wijaya Tbk. trades at Rp177 (market cap 788.61B, 31.24M 24h volume), while Merck Tbk. trades at Rp3,890 (market cap 1.75T, 29.1K 24h volume). The key difference: Merck Tbk. is far larger — about 2.2× Royalindo Investa Wijaya Tbk.'s market cap, and Royalindo Investa Wijaya Tbk. is more actively traded (31.24M versus 29.1K). Which is the better fit depends on your goals.

INDOMERK
Market Cap
788.61B1.75T
Volume
31.24M29.1K
Lot
312.38K291
Turnover
5.54B113.37M
Average Price
177.23,895.98
Value
5.54B113.37M
Indicative Equilibrium Price
1773,890
Indicative Equilibrium Volume
4101

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

INDO
View details
MERK
View details

About Royalindo Investa Wijaya Tbk.

PT Royalindo Investa Wijaya Tbk (the Company) was established based on Notarial Deed No. 19 dated July 6, 2005 of Tse Min Suhardi, S.H., a public notary in Jakarta. The Company started its commercial operations in July 6, 2005.

Read more on INDO

About Merck Tbk.

PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.

Read more on MERK